Brokerages Set Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) PT at $973.13
Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the twenty-five analysts that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, sixteen have given a buy […]
Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the twenty-five analysts that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, sixteen have given a buy […]
